RDY 150 (Capecitabine 150 mg)
Pill with imprint RDY 150 is Peach, Capsule-shape and has been identified as Capecitabine 150 mg. It is supplied by Dr. Reddy's Laboratories, Inc..
Capecitabine is used in the treatment of colorectal cancer; breast cancer, metastatic; breast cancer; anal cancer and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Capecitabine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RDY 150
Capecitabine
- Imprint
- RDY 150
- Strength
- 150 mg
- Color
- Peach
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antimetabolites
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy's Laboratories, Inc.
- National Drug Code (NDC)
- 55111-0496
More about capecitabine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 44 Reviews
- Drug class: antimetabolites
Patient resources
- Other brands
- Xeloda
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.